Author/Creator: Manyak, Michael - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Manyak, Michael

1. Bioequivalence Studies of a Reformulated Dutasteride and Tamsulosin Hydrochloride Combination Capsule and a Commercially Available Formulation. Issue 5 (27th January 2017)

Authors:: Kurczewski, Renee; Bowen, Chet; Collins, David; Zhu, John; Serbest, Gulyeter; Manyak, Michael
Journal:: Clinical pharmacology in drug development
Issue:: Volume 6:Issue 5(2017)
Page Start:: 508
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies. Issue 6 (3rd June 2018)

Authors:: Ong, Gary; Manyak, Michael; Lulic, Zrinka
Journal:: Expert opinion on drug safety
Issue:: Volume 17:Issue 6(2018)
Page Start:: 651
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Long‐term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. Issue 9 (19th February 2016)

Authors:: Tsunemi, Yuichiro; Irisawa, Ryokichi; Yoshiie, Hiromu; Brotherton, Betsy; Ito, Hisahiro; Tsuboi, Ryoji; Kawashima, Makoto; Manyak, Michael
Journal:: Journal of dermatology
Issue:: Volume 43:Issue 9(2016)
Page Start:: 1051
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Model‐based meta‐analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms. Issue 8 (14th April 2020)

Authors:: D'Agate, Salvatore; Wilson, Timothy; Adalig, Burkay; Manyak, Michael; Palacios‐Moreno, Juan Manuel; Chavan, Chandrashekhar; Oelke, Matthias; Roehrborn, Claus; Della Pasqua, Oscar
Journal:: British journal of clinical pharmacology
Issue:: Volume 86:Issue 8(2020)
Page Start:: 1585
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Model‐based meta‐analysis of the time to first acute urinary retention or benign prostatic hyperplasia‐related surgery in patients with moderate or severe symptoms. Issue 7 (19th January 2021)

Authors:: D'Agate, Salvatore; Chavan, Chandrashekhar; Manyak, Michael; Palacios‐Moreno, Juan Manuel; Oelke, Matthias; Michel, Martin C.; Roehrborn, Claus G.; Della Pasqua, Oscar
Journal:: British journal of clinical pharmacology
Issue:: Volume 87:Issue 7(2021)
Page Start:: 2777
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Superiority of dutasteride 0.5 mg and tamsulosin 0.2 mg for the treatment of moderate‐to‐severe benign prostatic hyperplasia in Asian men. (9th September 2018)

Authors:: Haque, Nazneen; Masumori, Naoya; Sakamoto, Sadaaki; Ye, Zhangqun; Yoon, Sang‐Jin; Kuo, Hann‐Chorng; Brotherton, Betsy; Wilson, Timothy; Muganurmath, Chandra; McLaughlin, Megan; Manyak, Michael
Journal:: International journal of urology
Issue:: Volume 25:Number 11(2018)
Page Start:: 944
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia–Pacific and Latin America. Issue 8 (31st March 2017)

Authors:: Lulic, Zrinka; Inui, Shigeki; Sim, Woo‐Young; Kang, Hoon; Choi, Gwang Seong; Hong, Woosung; Hatanaka, Toshiki; Wilson, Timothy; Manyak, Michael
Journal:: Journal of dermatology
Issue:: Volume 44:Issue 8(2017)
Page Start:: 892
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗